Sham procedure control: Clinical Trials

2 trials of Sham procedure control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1
Phase 11Recruiting 1

Follow Sham procedure control: new trials by email Literature Review of Sham procedure control trials Research Report on Sham procedure control

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
BS01, Sham procedure control - Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Phase 1 / Phase 2RecruitingBionic Sight LLC402026-01-082026-01-23
Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants
Human Allogenic Umbilical Cord Mesenchymal Stromal Cells, Sham procedure control - Bronchopulmonary Dysplasia (BPD), ELGAN (22-28SA)
Phase 2Not yet recruitingOttawa Hospital Research Institute1682025-10-012025-07-10

Conditions studied

Bronchopulmonary Dysplasia (1)  ·  Geographic Atrophy (1)  ·  Premature Birth (1)

Sponsors

Bionic Sight LLC (1)  ·  Ottawa Hospital Research Institute (1)

Countries

Canada (1)  ·  United States (1)

Results publications

PMID 42409407